Skip to main content

Day: March 15, 2022

Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series

– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary endpoint of overall survival compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line treatment for advanced NSCLC patients without EGFR/ALK mutations – SHANGHAI, China and REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus” ), today announced the presentation of positive results and biomarker analysis from the pivotal study “CHOICE-01” (clinicaltrials.gov identifier# NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous...

Continue reading

TILT Amends Purchase and Sale Agreement for its Taunton, Massachusetts Facility

PHOENIX, March 15, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO:TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, has signed an amendment (the “Amendment”) to its previously announced definitive agreement to exercise its purchase option for ownership of its Taunton, Mass. facility (the “Purchase Agreement”). Pursuant to the terms of the Amendment, TILT paid to extend the closing of the transactions contemplated by the Purchase Agreement to a date that is on or before May 31, 2022. The mutually agreed-upon Amendment also extends the due diligence period and the deadline to determine whether TILT will acquire both Unit A and Unit B of the condominium comprising the Taunton...

Continue reading

CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022

Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that the company will release its 2021 fourth quarter and full year financial results after the market closes on Tuesday, March 29, 2022. Management will host a conference call and webcast at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on the company’s business. Details for the Conference Call:Date: March 29, 2022Time: 5:00 p.m. ET (2:00 p.m. PT)   Conference Audio–  Dial-in U.S. and Canada: (877) 451-6152–  Dial-in...

Continue reading

eXp Realty Now Open in 20 Markets With the Addition of Brokerage Operations in Greece

eXp Realty Launches Brokerage Operations in Greece eXp Realty Now Open in 20 Markets With the Addition of Brokerage Operations in GreeceBELLINGHAM, Wash., March 15, 2022 (GLOBE NEWSWIRE) — eXp Realty®, the fastest-growing global real estate brokerage and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), has expanded into Greece. eXp Realty now operates in 20 markets with more than 77,000 agents around the world. “This is a proud moment for eXp Realty as we expand to our 20th market, with the addition of Greece to our well-established operations across Europe,” said Michael Valdes, President of eXp Global, who is responsible for eXp Realty’s worldwide expansion. “Greece is a vibrant market with strong economic projections driven by tourism and excellent foreign investment opportunities. We see tremendous business...

Continue reading

Verizon Business Expands BlueJeans Telehealth for Data-Driven Virtual Care, Everywhere

What You Need to Know:Data source expansion and new data integration capabilities in BlueJeans Telehealth include Command Center for analytics and the ability to share additional Apple Health app data in the coming months Integration with Redox provides reliable communication and interoperability with more than 85 Enterprise Health Record (EHR) systemsNEW YORK, March 15, 2022 (GLOBE NEWSWIRE) — Verizon Business today announced enhanced access to new data sources and new partner integrations for BlueJeans Telehealth, a purpose-built, HIPAA-ready video conferencing solution designed to help drive better patient interactions. Building on the platform’s accessibility and ease-of use, the latest enhancements to BlueJeans Telehealth were designed to help improve the overall quality of virtual care. “Telehealth not only improves...

Continue reading

Hubbell Incorporated Recognized as One of the 2022 World’s Most Ethical Companies

Shelton, CT, March 15, 2022 (GLOBE NEWSWIRE) —       Hubbell Incorporated (NYSE: HUBB) has been recognized as one of the 2022 World’s Most Ethical Companies by Ethisphere. This is the second time Hubbell has achieved this recognition.  Hubbell’s Chairman, President and Chief Executive Officer, Gerben Bakker stated, “We are honored to be listed among the World’s Most Ethical Companies for the second consecutive year. This recognition evidences the strong ethical culture that Hubbell’s employees demonstrate every day. Acting with integrity is a core part of our values and at Hubbell, how we do our work is just as important as the results we achieve.” In 2022, 136 companies were recognized, spanning 22 countries and 45 industries.  Ethisphere’s assessment process focuses on culture, environmental and social practices, ethics and...

Continue reading

Sigyn Therapeutics™ Appoints H. David Humes, MD to Its Scientific Advisory Board

SAN DIEGO, CA, March 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on the treatment of pathogen-associated conditions that induce sepsis and other life-threatening disorders, today announced the appointment of H. David Humes, MD to its Scientific Advisory Board.  Dr. Humes is an internationally respected thought leader whose medical expertise is highly regarded across multiple industry segments. He has recently played an instrumental role in the oversight of preclinical and animal studies of Sigyn Therapy and is anticipated to be a valuable contributor to the further clinical advancement of Sigyn Therapy. Sigyn Therapy is an extracorporeal blood purification technology designed to overcome the limitations of previous drugs and devices to treat...

Continue reading

Mile Auto Enhances Insurance Experience for Low-Mileage Drivers with Verisk Telematics

Through Verisk’s mileage-based telematics solutions, Mile Auto can streamline the insurance purchase experience and reach new customers Jersey City, N.J. and Atlanta, GA, March 15, 2022 (GLOBE NEWSWIRE) — Insurtech innovator Mile Auto has integrated telematics solutions from Verisk (Nasdaq:VRSK), a leading global data analytics provider, to help consenting, low-mileage drivers easily access affordable car insurance based on how much they drive. By connecting to the Verisk Data Exchange™ and its network of automakers, Mile Auto will be able to deliver an efficient, customer-centric purchase experience to the growing number of connected car drivers. Mile Auto is fueling its growth as a managing general agent (MGA) by using two Verisk solutions: Discount Alert and DrivingDNA Mileage. With Discount Alert, Mile Auto will be able to...

Continue reading

NextPlay Technologies Partners with TruCash Group of Companies to Launch Worldwide Payments Platform and offer International Banking Services to Millions of Account Holders

SUNRISE, FL, March 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – NextPlay Technologies, Inc. (Nasdaq: NXTP), announced that NextBank International, the international banking unit of its fintech division, has partnered with TruCash Group of Companies Inc., a leading global payments provider, to launch NextBank Payments, which will include (but not be limited to) Mobile Wallets, Mobile Payments, Credit cards, Debit Cards, and Prepaid products.  In addition, NextBank will have the opportunity to offer NextBank’s international banking services to TruCash’s millions of account holders worldwide. Through its unique partnerships with top global networks, TruCash provides customized prepaid Visa® card solutions that offer a full range of payment options, benefits and rewards. TruCash will provide NextBank a comprehensive mobile wallet,...

Continue reading

HANMI Releases 2021 Annual Shareholder Letter

LOS ANGELES, March 15, 2022 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced the release of its 2021 annual letter to shareholders (entitled “Celebrating 40 Years of Success – Helping Our Customers Bank on Their Dreams”) authored by President and Chief Executive Officer Bonnie Lee. To view the letter please visit https://investors.hanmi.com/company-information. About Hanmi Financial Corporation Headquartered in Los Angeles, California, Hanmi Financial Corporation owns Hanmi Bank, which serves multi-ethnic communities through its network of 35 full-service branches and eight loan production offices in California, Texas, Illinois, Virginia, New Jersey, New York, Colorado, Washington and Georgia. Hanmi Bank specializes in real estate, commercial,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.